medinfoАктуальные проблемы теоретической и клинической медициныActual Problems of Theoretical and Clinical Medicine2790-12892790-1297Казахстанско-Российский медицинский университетmedinfo-179Research ArticleСтатьиПроблема избыточного веса в мире (обзор литературы)РахметоваК. У.МаншариповаА. Т.БекетоваС. К.НУО «Казахстанско-Российский медицинский университет»Казахстан201910112022044950Copyright © Рахметова К.У., Маншарипова А.Т., Бекетова С.К., 20222022Рахметова К.У., Маншарипова А.Т., Бекетова С.К.Рахметова К.У., Маншарипова А.Т., Бекетова С.К.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://kazrosmedjournal.krmu.edu.kz/jour/article/view/179
.
ReferencesИвлева А.Я., Старостина Е.Г. Ожирение – проблема медицинская. – М.: 2002. – 176 с.Ивлева А.Я., Старостина Е.Г. Ожирение – проблема медицинская. – М.: 2002. – 176 с.American Obesity Association. AOA fact Sheets: Obesity in the USA // www. Obesity.org. 2007.American Obesity Association. AOA fact Sheets: Obesity in the USA // www. Obesity.org. 2007.De Koning L., Merchant A.T., Pogue J., Anand S.S. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies // Eur. Heart J., 2007; 2: P. 850–856.De Koning L., Merchant A.T., Pogue J., Anand S.S. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies // Eur. Heart J., 2007; 2: P. 850–856.Lavie C.J., Milani R.V., Artham S.M. et al. The obesity paradox, weight loss, and coronary disease // Am. J. Med., 2009;12: P. 1106–1114.Lavie C.J., Milani R.V., Artham S.M. et al. The obesity paradox, weight loss, and coronary disease // Am. J. Med., 2009;12: P. 1106–1114.Бессен Д.Г., Кушнер Р. Избыточный вес и ожирение. Профилактика, диагностика и лечение. – М.: ЗАО «Изд. БИНОМ», 2004. – 240 с.Бессен Д.Г., Кушнер Р. Избыточный вес и ожирение. Профилактика, диагностика и лечение. – М.: ЗАО «Изд. БИНОМ», 2004. – 240 с.Bray G.A., Blakburn G.L., Ferguson J.M. et al. Sibutramine produces dose-related weight loss // Obesity Res., 1999; 7: P. 189–198.Bray G.A., Blakburn G.L., Ferguson J.M. et al. Sibutramine produces dose-related weight loss // Obesity Res., 1999; 7: P. 189–198.Hubert H.B., Feinleib M., McNamara P.H. Obesity as an independent risk factor for cardiovascular disease: a 26-yeae follow-up of participants in the Framingham Heart Study // Circulation, 1993;Hubert H.B., Feinleib M., McNamara P.H. Obesity as an independent risk factor for cardiovascular disease: a 26-yeae follow-up of participants in the Framingham Heart Study // Circulation, 1993;Hellmich N. Obesity linked to specific cancers // USA TODAY, 2009. – 11. – 05. 10: P.Hellmich N. Obesity linked to specific cancers // USA TODAY, 2009. – 11. – 05. 10: P.Moklad A.H., Bowman B.A., Ford E.S. et al. The continuing epidemics of obesity and diabetes in the United States // JAMA, 2001; 11: P. 1195–1200.Moklad A.H., Bowman B.A., Ford E.S. et al. The continuing epidemics of obesity and diabetes in the United States // JAMA, 2001; 11: P. 1195–1200.Obesity impact on GER symptoms examined // www. Medwirenews. md. 2009.Obesity impact on GER symptoms examined // www. Medwirenews. md. 2009.Sjostrom L., Rissanen A., Andersen T. et al. Randomized placebocontrolled trial of orlistat for weight loss and prevention of weight regain in obese patients // Lancet,2008; 5: P. 167–172.Sjostrom L., Rissanen A., Andersen T. et al. Randomized placebocontrolled trial of orlistat for weight loss and prevention of weight regain in obese patients // Lancet,2008; 5: P. 167–172.
The authors declare that there are no conflicts of interest present.